NEIMETH International Pharmaceuticals Plc has declared a dividend of seven kobo for every 50kobo share held of the company, an eight per cent increase over the 6.5 kobo paid by the company last year. The firm said in a statement that this marks the second consecutive payment of dividend by the healthcare company after over a decade of non-payment of dividend to shareholders. It said at the annual general meeting of the company, the shareholders approved the dividends with words of gratitude to the board and management for keeping their promise on the sustenance and increase in dividends. Speaking at the meeting in Lagos, the Chairman of the Board of Directors, Dr Ambrosie Orjiako, said the plan of the board was to effectively end the era of losses and non-payment of dividends. He assured the shareholders that the board would work with the management to continue to improve on returns to shareholders. In the 2021 business year, the statement said the turnover of the company grew by seven per cent while profit before tax grew 23 per cent. Profit after tax grew by 27 per cent compared to 2020, it added. Neimeth noted it had emerged from an era of constant losses to a period of steady growth. The statement said, “In the past three years the company has built a regime of growth and profitability.  In the 2018/2019 and 2019/2020 business years the company recorded growth in both turnover and profit after ten years of lull.” Copyright PUNCH. All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from PUNCH. Contact: theeditor@punchng.com